Cargando…
Leczyme: A New Candidate Drug for Cancer Therapy
Sialic acid-binding lectin (SBL), isolated from oocytes of Rana catesbeiana, is leczyme and has both lectin and ribonuclease (RNase) activities. A remarkable antitumor effect of SBL has also been reported. SBL agglutinates various kinds of tumor cells but not normal cells. SBL agglutination activity...
Autores principales: | Tatsuta, Takeo, Sugawara, Shigeki, Takahashi, Kohta, Ogawa, Yukiko, Hosono, Masahiro, Nitta, Kazuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017849/ https://www.ncbi.nlm.nih.gov/pubmed/24864241 http://dx.doi.org/10.1155/2014/421415 |
Ejemplares similares
-
Cancer-Selective Induction of Apoptosis by Leczyme
por: Tatsuta, Takeo, et al.
Publicado: (2014) -
Downregulation of Hsp70 inhibits apoptosis induced by sialic acid-binding lectin (leczyme)
por: TATSUTA, TAKEO, et al.
Publicado: (2014) -
Sialic acid-binding lectin (leczyme) induces apoptosis to malignant mesothelioma and exerts synergistic antitumor effects with TRAIL
por: TATSUTA, TAKEO, et al.
Publicado: (2013) -
Sialic acid-binding lectin (leczyme) induces caspase-dependent apoptosis-mediated mitochondrial perturbation in Jurkat cells
por: TATSUTA, TAKEO, et al.
Publicado: (2013) -
Involvement of ER stress in apoptosis induced by sialic acid-binding lectin (leczyme) from bullfrog eggs
por: TATSUTA, TAKEO, et al.
Publicado: (2013)